Welcome to our Discover Cannabis series, where we publish in-depth research to introduce new cannabis companies to our coverage.
Introduction
CV Sciences (OTCQB:CVSI) looks like a promising CBD play on a first glance. The U.S.-based CBD company has seen its ups and downs in the past few years as it went through the 2014 bubble when its share price surged to more than $100 before falling back to become a penny stock. Despite fast-growing sales, the troubled history of its management and governance still haunts the company and gave us pause before recommending